Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
HitIQ Limited ( (AU:HIQ) ) has provided an announcement.
HITIQ Limited announced the receipt of approximately $1.6 million from the R&D Tax Incentive Scheme. A significant portion of this funding, around $1.472 million, was used to repay funds owed under a previous RDTI facility arrangement with Keystone Capital Partners, with the remaining balance incorporated into a new facility for 2025. This financial maneuver is expected to support the company’s ongoing operations and potentially enhance its industry positioning as a provider of innovative brain care solutions.
More about HitIQ Limited
HITIQ is a brain care solutions company that provides advanced technologies such as sensor-enabled mouthguards and AI-powered data analytics interfaces. They focus on enhancing concussion management for sports players and offer return-to-play/work support software. Their clientele includes major sports leagues like the AFL, EPL, and NRL, as well as universities and research organizations.
YTD Price Performance: 0%
Average Trading Volume: 376,092
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$17.43M
For detailed information about HIQ stock, go to TipRanks’ Stock Analysis page.
